MANCHESTER KEITH S 4
4 · Roivant Sciences Ltd. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
MANCHESTER KEITH S
Director
Transactions
- Sale
Common Shares
2025-12-16$22.93/sh−275,000$6,305,750→ 17,772,727 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-16$23.08/sh−642,282$14,823,869→ 17,130,445 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-17$23.05/sh−432,718$9,974,150→ 16,697,727 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-17$23.02/sh−155,076$3,569,850→ 16,542,651 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-17$23.17/sh−189,538$4,391,595→ 16,353,113 total(indirect: Held by QVT Financial Investment Cayman Ltd.)
Footnotes (1)
- [F1]The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.